Undervalued over 20% based on DCF

Results

5119

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

5119 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
GOOGL
US$336.71-1.6%71.3%US$4.1tUS$427.5916.9-0.7%0.3%Media
MSFT
US$390.540.05%-23.9%US$2.9tUS$555.7723.213.7%0.9%Software
META
US$585.61-6.6%-15.8%US$1.5tUS$824.6821.113.8%0.4%Media
BRK.A
US$763,167.004.2%6.9%US$1.1tUS$764,712.0015.1-2.4%n/aDiversified Financials
LLY
US$1,210.024.0%59.2%US$1.1tUS$1,276.9642.716.6%0.6%Pharmaceuticals & Biotech
JPM
US$344.71-1.0%15.0%US$949.8bUS$371.852.61.4%1.7%Banks
JNJ
US$265.533.9%58.8%US$642.8bUS$270.5930.49.8%2.0%Pharmaceuticals & Biotech
XOM
US$156.751.5%40.1%US$634.3bUS$167.2325.79.6%2.6%Energy
688825
CN¥52.87n/an/aCN¥3.5tCN¥61.70125.427.7%n/aSemiconductors
ABBV
US$263.303.9%39.1%US$465.0bUS$268.68129.427.3%2.6%Pharmaceuticals & Biotech
CVX
US$191.86-0.6%24.9%US$370.9bUS$215.0034.511.1%3.7%Energy
HSBA
UK£15.480.4%67.1%UK£265.4bUK£14.661.811.3%3.6%Banks
PG
US$146.10-2.0%-4.4%US$346.7bUS$163.4820.83.4%3.0%Household
MRK
US$130.362.3%59.5%US$325.6bUS$135.1936.021.2%2.6%Pharmaceuticals & Biotech
NFLX
US$73.637.4%-37.8%US$301.4bUS$94.3322.511.4%n/aMedia
PLTR
US$123.00-1.3%-22.5%US$296.1bUS$182.20129.231.9%n/aSoftware
AZN
UK£131.343.4%14.2%UK£203.7bUK£159.1126.013.8%1.8%Pharmaceuticals & Biotech
BABA
US$115.03-1.3%-2.0%US$262.8bUS$189.3716.815.5%0.9%Retail
WFC
US$83.87-3.0%2.6%US$262.7bUS$100.021.53.3%2.4%Banks
NESN
CHF 82.71-4.0%15.8%CHF 212.7bCHF 88.8728.612.7%3.7%Food, Beverage & Tobacco
DELL
US$369.64-16.3%176.8%US$253.4bUS$502.7828.416.8%0.7%Tech
8306
JP¥3,520.00-6.1%66.8%JP¥41.0tJP¥3,596.362.012.2%2.7%Banks
SIE
€271.250%18.5%€207.8b€295.1527.312.5%2.0%Capital Goods
AXP
US$331.50-4.9%9.3%US$227.3bUS$374.5419.89.3%1.1%Diversified Financials
Page 1 of 143
Undervalued over 20% based on DCF - Investing Ideas - Simply Wall St